AstraZeneca
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 32 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.4 percentage points.
Institutional ownership
- Held by institutions
- 74.72% -0.39pp
- Institutions
- 2,218 -32
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-02-02
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
12 filings tracked · 7 buys · 2 sells
| Name | Role | Stake |
|---|---|---|
| Aradhana Sarin | Executive Director | 0.01% |
| Mani Sharma | -- | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Mani Sharma | -- | Other Acquisition | +2 | $159.80 |
| 2026-09-07 | Mani Sharma | -- | Other Acquisition | +1 | $162.60 |
| 2026-08-07 | Mani Sharma | -- | Private Acquisition | +20 | $160.57 |
| 2026-08-05 | Mani Sharma | -- | Other Acquisition | +2 | $163.34 |
| 2026-07-05 | Mani Sharma | -- | Other Acquisition | +2 | $190.43 |
| 2026-06-07 | Mani Sharma | -- | Other Acquisition | +1 | $179.75 |
| 2026-05-19 | Mani Sharma | -- | Private Disposition | -11,893 | $185.78 |
| 2026-05-05 | Mani Sharma | -- | Other Acquisition | +2 | $186.28–196.03 |
| 2026-03-17 | Mani Sharma | -- | Initial Statement of Beneficial | 0 | -- |
| 2025-11-11 | Aradhana Sarin | Chief Financial Officer | Intent to Sell (Form 144) | -15,000 | $88.88 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-20 06:37:53 · For reference only, not investment advice and not tailored to your situation.
AstraZeneca discussion 0 comments